Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lidia Ruiz-Llorente, Eunate Gallardo-Vara, Elisa Rossi, David M. Smadja, Luisa M. Botella & Carmelo Bernabeu. (2017) Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Expert Opinion on Therapeutic Targets 21:10, pages 933-947.
Read now
Read now
J Kochanowski, M Sobieszczańska, S Tubek, M Żurek & J Pawełczak. (2015) Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia. Human Vaccines & Immunotherapeutics 11:3, pages 680-681.
Read now
Read now
Articles from other publishers (22)
Li Xiang-Tischhauser, Michael Bette, Johanna R. Rusche, Katrin Roth, Norio Kasahara, Boris A. Stuck, Udo Bakowsky, Maria Wartenberg, Heinrich Sauer, Urban W. Geisthoff & Robert Mandic. (2023) Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis. Cells 12:12, pages 1600.
Crossref
Crossref
L. J. Walsh, C. Collins, H. Ibrahim, D. M. Kerins, A. P. Brady & T. M. O Connor. (2022) Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report. Journal of Medical Case Reports 16:1.
Crossref
Crossref
Reade De Leacy, Sameer A Ansari, Clemens M Schirmer, Daniel L Cooke, Charles J Prestigiacomo, Ketan R Bulsara & Steven W Hetts. (2022) Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee. Journal of NeuroInterventional Surgery 14:11, pages 1118-1124.
Crossref
Crossref
Fabiola Sârbu, Violeta Diana Oprea, Alin Laurențiu Tatu, Eduard Polea Drima, Violeta Claudia Bojincă & Aurelia Romila. (2022) Hereditary Hemorrhagic Telangiectasia Associating Neuropsychiatric Manifestations with a Significant Impact on Disease Management—Case Report and Literature Review. Life 12:7, pages 1059.
Crossref
Crossref
Vani Venugopal & S. Sumi. (2022) Molecular Biomarkers and Drug Targets in Brain Arteriovenous and Cavernous Malformations: Where Are We?. Stroke 53:1, pages 279-289.
Crossref
Crossref
N. V. Boiko. (2020) Modern diagnosis and treatment of hereditary hemorrhagic telangiectasia. Rossiiskaya rinologiya 28:1, pages 20.
Crossref
Crossref
Angela M. Crist, Amanda R. Lee, Nehal R. Patel, Dawn E. Westhoff & Stryder M. Meadows. (2018) Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia. Angiogenesis 21:2, pages 363-380.
Crossref
Crossref
James R. Gossage. (2018) The Current Role of Bevacizumab in the Treatment of Hereditary Hemorrhagic Telangiectasia–Related Bleeding. Mayo Clinic Proceedings 93:2, pages 130-132.
Crossref
Crossref
Patricia E. Burrows. 2017. Congenital Vascular Malformations. Congenital Vascular Malformations
343
347
.
Freya Droege, Kruthika Thangavelu, Stephan Lang & Urban Geisthoff. (2016) Improvement in hereditary hemorrhagic telangiectasia after treatment with the multi-kinase inhibitor Sunitinib. Annals of Hematology 95:12, pages 2077-2078.
Crossref
Crossref
Y. Troumani, F. Ackermann, S. Cohen, S. Touhami, G. Nasser, C. Denier, M. Labetoulle & A. Rousseau. (2016) Coats Plus : la version systémique de la maladie de Coats. Journal Français d'Ophtalmologie 39:7, pages e167-e170.
Crossref
Crossref
S Jervis & D Skinner. (2016) Screening for arteriovenous malformations in hereditary haemorrhagic telangiectasia. The Journal of Laryngology & Otology 130:8, pages 734-742.
Crossref
Crossref
Melissa A. Lyle, Eric R. Fenstad, Michael D. McGoon, Robert P. Frantz, Michael J. Krowka, Garvan C. Kane & Karen L. Swanson. (2016) Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Chest 149:2, pages 362-371.
Crossref
Crossref
Anne C. Travis & Joshua R. Korzenik. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
2470
2489
.
J. P. Boey, U. Hahn, S. Sagheer & S. J. McRae. (2015) Thalidomide in angiodysplasia-related bleeding. Internal Medicine Journal 45:9, pages 972-976.
Crossref
Crossref
Mary E. Sehl, Theresa M. Gruber, Justin P. McWilliams & Victor J. Marder. (2015) Successful management of chronic gastrointestinal hemorrhage using bevacizumab in the setting of hereditary hemorrhagic telangiectasia. American Journal of Hematology 90:6, pages 561-563.
Crossref
Crossref
Kira Young, Eric Tweedie, Barbara Conley, Jacquelyn Ames, MaryLynn FitzSimons, Peter Brooks, Lucy Liaw & Calvin P. H. Vary. (2015) BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses. PLOS ONE 10:4, pages e0122892.
Crossref
Crossref
Luisa-MarÃa Botella, Virginia Albiñana, Luisa Ojeda-Fernandez, Lucia Recio-Poveda & Carmelo Bernabéu. (2015) Research on potential biomarkers in hereditary hemorrhagic telangiectasia. Frontiers in Genetics 6.
Crossref
Crossref
Simon Tual-Chalot, S. Paul Oh & Helen M. Arthur. (2015) Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges. Frontiers in Genetics 6.
Crossref
Crossref
Rupal S. Bhatt & Michael B. Atkins. (2014) Molecular Pathways: Can Activin-like Kinase Pathway Inhibition Enhance the Limited Efficacy of VEGF Inhibitors?. Clinical Cancer Research 20:11, pages 2838-2845.
Crossref
Crossref
Jose W. Ruiz, Mohammad Al-bar, Giannina Robalino & Raphael Nwojo. (2014) Current update on office-based procedures in rhinology. Operative Techniques in Otolaryngology-Head and Neck Surgery 25:2, pages 201-205.
Crossref
Crossref
Deepak Atri, Bruno Larrivée, Anne Eichmann & Michael Simons. (2013) Endothelial signaling and the molecular basis of arteriovenous malformation. Cellular and Molecular Life Sciences 71:5, pages 867-883.
Crossref
Crossref